PHaLIR: prevent hernia after loop ileostomy reversal-a study protocol for a randomized controlled multicenter study.
Karolina Eklöv, Sven Bringman, Jenny Löfgren...
https://pubmed.ncbi.nlm.nih.gov/37684648/Actively Recruiting
Led by Karolinska Institutet · Updated on 2025-08-19
208
Participants Needed
4
Research Sites
156 weeks
Total Duration
This research aims to evaluate ways to prevent hernia after loop ileostomy reversal in patients who have undergone rectal cancer surgery. A loop ileostomy is a temporary opening created during rectal cancer surgery that is later closed in a separate operation. Hernia, a weakening of the abdominal wall at the stoma site, can cause pain, discomfort, and serious complications, and its frequency after ileostomy reversal varies widely. This study compares the use of a protective mesh to standard closure methods to see if hernia rates can be reduced. Participants will be randomly assigned to one of two groups one group will receive reinforcement of the abdominal wall with a mesh called Ultrapro Advanced, placed behind the muscles the other group will have the stoma site closed using standard suturing without mesh. The study is double-blinded, meaning neither patients nor surgeons recording follow-up data know which treatment was given. Procedures and outcomes such as operation time, complications, hospital stay, pain, and infections will be carefully recorded. Participants will be monitored before and after surgery, including a 30-day follow-up visit with questionnaires and complication assessments by a doctor not involved in the surgery. One year after the cancer operationwhich generally occurs 6 to 9 months after ileostomy reversalpatients will have a CT scan with straining to check for hernia and complete questionnaires. Further follow-up with questionnaires and imaging will occur at three years. The study involves detailed tracking of post-surgical recovery and hernia development over several years.
CONDITIONS
Prevention of Hernia After Loop Ileostomy Reversal
Å
Åsa Hallqvist Everhov, MD, PhD
J
Jonas Nygren, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Karolinska Institutet
Lead Sponsor
Stockholm South General Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Hospital stay of approximately 7 days
Participants undergo loop ileostomy reversal surgery with either mesh reinforcement or standard closure of the abdominal wall.
Hospital stay with daily assessments
Duration - 30 days post-surgery
Participants attend follow-up visits to assess pain, complications, and recovery after surgery.
1 follow-up visit at 30 days post-operation
Duration - Up to 3 years
Participants are monitored for hernia development and overall recovery up to three years after surgery, including questionnaires and imaging assessments.
Clinical visits or telephone calls at 6-9 months and 3 years post-surgery, with questionnaires and CT scans
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Karolina Eklöv, Sven Bringman, Jenny Löfgren...
https://pubmed.ncbi.nlm.nih.gov/37684648/Karolinska Institutet
Lead Sponsor
Stockholm South General Hospital
Collaborating Sponsor